Valeant Pharmaceuticals and Mentor Worldwide have collaborated to create a joint physician loyalty program called the M2VP Program (Medicis-Mentor Valued Partner Program).
The terms of the collaboration agreement extend the offerings of Medicis’ MVP program, which encompassed the company’s non-reimbursed facial aesthetics products, including neurotoxin, fillers and skincare. The new terms will now also include Mentor’s line of breast implant products for the aesthetics (non-reimbursed) market for a five-year term, according to a company statement.
“With this program we are providing our customers with opportunities for volume-based cost savings on the products they use and added incentives to try other products from our combined portfolios,” said Ryan Weldon, President of Medicis. “We believe that the M2VP program is one of the most comprehensive loyalty programs in the industry and will bring value to all practices, both large and small. The addition of Mentor’s breast aesthetic portfolio is truly exciting news for our customers and we are excited about future iterations of the program to come.”
The collaboration will allow participating members to earn points that establish status within the program, as well as to redeem the points for items such as product purchases. Physicians interested in participating should contact their local Medicis or Mentor sales representative for more information.
